NSB Hi All, back from holidays down the coast! Happy to share my investment report in relation to NSB (with my personal technical in and buy in/out targets concealed! ). I outline all the current positive aspects of it's trajectory, and model a DCF valuation based on current 2020 data on the MS pharma industry. The chart is also looking primed for a run on the daily and hourly, with the ST 2,5,3 MACD and Slow Stoch looking good, and a good OBV. Breakout of the recent downtrend has now occurred. See below. Really, this is in the same early stages as PNV and COH were after they proved their tech (now MCs of 1.51 and 13 B respectively), NSB already has inked a manufacturing deal with Mitsubishi. I also like their balance sheet for any M&A discussions (which are surely happening right now), as they have 3+ years runway. So, check out NSB, and the awesome results related to their EmtinB MS drug, and consider the technicals. This definitely is a multibagger target in the coming weeks (only 12M MC!), and I have been acquiring during the low volume days for the next leg up. The run to 50c is imminent IMO, and any further announcement of progression by the coy will see this move towards $1. Small SOI too, with only $78M, and no need for cap raise. Having been trading for 14 years, this is one of the best FA and TA setups for an early stage medtech I have seen. Anyway, the info is yours to consider. I recommend you keep NSB on your watchlists, and check out their most recent announcements asap, so that you can benefit from the coming uplift. If it is your kind of trad, then best of luck trading! Much love, Traz
). I outline all the current positive aspects of it's trajectory, and model a DCF valuation based on current 2020 data on the MS pharma industry.
